Cooper Other Long-Term Assets 2010-2024 | COO

Cooper other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Cooper other long-term assets for the quarter ending July 31, 2024 were $0.621B, a 1.08% decline year-over-year.
  • Cooper other long-term assets for 2023 were $0.637B, a 8.37% increase from 2022.
  • Cooper other long-term assets for 2022 were $0.588B, a 46.54% increase from 2021.
  • Cooper other long-term assets for 2021 were $0.401B, a 282.82% increase from 2020.
Cooper Annual Other Long-Term Assets
(Millions of US $)
2023 $637
2022 $588
2021 $401
2020 $105
2019 $67
2018 $74
2017 $76
2016 $52
2015 $39
2014 $39
2013 $47
2012 $44
2011 $48
2010 $41
2009 $46
Cooper Quarterly Other Long-Term Assets
(Millions of US $)
2024-07-31 $621
2024-04-30 $637
2024-01-31 $617
2023-10-31 $637
2023-07-31 $628
2023-04-30 $585
2023-01-31 $569
2022-10-31 $588
2022-07-31 $306
2022-04-30 $317
2022-01-31 $169
2021-10-31 $401
2021-07-31 $117
2021-04-30 $119
2021-01-31 $106
2020-10-31 $105
2020-07-31 $94
2020-04-30 $78
2020-01-31 $70
2019-10-31 $67
2019-07-31 $64
2019-04-30 $61
2019-01-31 $63
2018-10-31 $74
2018-07-31 $75
2018-04-30 $76
2018-01-31 $76
2017-10-31 $76
2017-07-31 $68
2017-04-30 $58
2017-01-31 $58
2016-10-31 $52
2016-07-31 $52
2016-04-30 $46
2016-01-31 $39
2015-10-31 $39
2015-07-31 $33
2015-04-30 $34
2015-01-31 $36
2014-10-31 $39
2014-07-31 $42
2014-04-30 $45
2014-01-31 $47
2013-10-31 $47
2013-07-31 $48
2013-04-30 $48
2013-01-31 $46
2012-10-31 $44
2012-07-31 $45
2012-04-30 $45
2012-01-31 $45
2011-10-31 $48
2011-07-31 $47
2011-04-30 $45
2011-01-31 $48
2010-10-31 $41
2010-07-31 $41
2010-04-30 $42
2010-01-31 $44
2009-10-31 $46
2009-07-31 $46
2009-04-30 $38
2009-01-31 $36
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.623B $3.593B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
CONMED (CNMD) United States $2.312B 19.29
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74